Atlas Trials

Etoposide in the First-line Treatment of Adult EBV-HLH

Clinical trial NCT03742115 · UNKNOWN

Trial details

NCT number
NCT03742115
Sponsor
Beijing Friendship Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hemophagocytic Lymphohistiocytosis
Start date
2018-12-01
Primary completion
2019-12-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.